The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis

AIM: Early prediction of (non-)response to infliximab therapy can improve therapeutic benefit by avoiding unnecessary periods of high disease activity during ineffective therapy. This prospective cohort study therefore aimed to study the predictive value of (1) disease activity alone and (2) inflixi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van den Bemt, Bart J F, den Broeder, Alfons A, Wolbink, Gert-Jan, van den Maas, Aatke, Hekster, Yechiel A, van Riel, Piet L C M, Benraad, H Bart, van den Hoogen, Frank H J
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2013
Assuntos:
Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3845317/
https://ncbi.nlm.nih.gov/pubmed/23601129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados